Liver transplantation at the millennium: Past, present, and future

Clinics in Liver Disease

Volumn 4, Issue 1, 2000, Pages 241-255

  Keeffe, Emmet B ^b  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; MERCAPTOPURINE; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; POLYCLONAL ANTIBODY; PREDNISONE; RAPAMYCIN; TACROLIMUS;

CELL TRANSPLANTATION; GENE THERAPY; HISTORY OF MEDICINE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL; LIVER TRANSPLANTATION; NONHUMAN; ORGAN DONOR; REVIEW; SURVIVAL; TREATMENT OUTCOME; XENOTRANSPLANTATION;

EID: 0034425156     PISSN: 10893261     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1089-3261(05)70106-9     Document Type: Article

References (70)

1. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation. The U.S. Multicenter FK506 Liver Study Group
2. Canine and human liver preservation for 6 to 18 hours by cold infusion
3. Pilot study of the combination of interferon alfa and ribavirin as therapy of recurrent hepatitis C after liver transplantation
4. Influence of donor and recipient gender on the outcome of liver transplantation
5. The debate over liver allocation in the United States: The UNOS perspective
6. Primary liver transplantation without transfusion of red blood cells
7. Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaver organs: 32 kidneys, 2 pancreases, and 2 livers
8. Prolonged survival of pig orthotopic heart grafts treated with cyclosporin A
9. Cyclosporin A in patients receiving renal allografts from cadaver donors
10. Liver transplantation in man. I. Observations on technique and organization in five cases
11. Brief report
12. Anaesthesia for hepatic transplantation: Cardiovascular and metabolic alterations and their management
13. Forward: Prospects of liver cell transplantation and liver-directed gene therapy
14. Ethics of xenotransplantation: Animal issues, consent, and likely transformation of transplant ethics
15. Recurrent disease after liver transplantation
16. Tentative d'homograffe hépafique (Attempted hepatic homograft)
17. Immunosuppressive strategies in transplantation
18. Influence of donor age on graft survival after transplantation-United Network for Organ Sharing Registry
19. Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases liver transplantation database
20. The "arithmetic" of donor liver allocation
21. Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients
22. Infection in organ-transplant recipients
23. The rationale for equitable liver allocation
24. A randomized study comparing ribavirin and interferon alfa monotherapy for hepatitis C recurrence after liver transplantation
25. Compensated cirrhosis: Natural history and prognostic factors
26. Donor age and outcome of liver transplantation
27. Experience in 1,000 liver transplants under cyclosporine-steroid therapy: A survival report
28. Successful 24- to 30-hour preservation of the canine liver: A preliminary report
29. Extended preservation of the liver for clinical transplantation
30. Summary of guidelines on organ allocation and patient listing for liver transplantation
31. Adult-to-adult living donor liver transplantation using extended right lobe grafts
32. Applicability of living donor liver transplantation to high-urgency patients
33. Minimal criteria for placement of adults on the liver transplant waiting list: A report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases
34. Living donor liver transplantation (LDLTx) for adults utilizing the right lobe
35. Effect of donor age and sex on the outcome of liver transplantation
36. Second study of behavior of skin homografts in rabbits
37. The behavior and fate of skin autografts and skin homografts in rabbits
38. Immunosuppression and vascular insufficiency in liver transplantation
39. One-stage homotransplantation of the liver following total hepatectomy in dogs
40. Experimental whole organ transplantation of the liver and of the spleen
41. Progress in xenotransplantation
42. National Institutes of Health Consensus Development Conference Statement: Liver transplantation-June 20-23, 1983
43. Comparison of quadruple immunosuppression after liver transplantation with ATG or IL-2 receptor antibody
44. Allocation of livers for liver transplantation: Ethics and politics
45. Hepatitis C infection in transplantation
46. Prognosis and life expectancy in chronic liver disease
47. Randomised trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection
48. Monoclonal antibodies in prophylactic immunosuppression after liver transplantation
49. Liver transplantation in the United States from 1987-1998: Updated results from the Pitt-UNOS liver transplant registry
50. Venous bypass in clinical liver transplantation
51. Quality of life, functional status, and depression in male liver transplant recipients with recurrent viral hepatitis C
52. Liver allograft rejection: An analysis of the use of biopsy in determining the outcome of rejection
53. History of liver and other splanchnic organ transplantation
54. Evolution of liver transplantation
55. Reconstructive problems in canine liver homotransplantation with special reference to the postoperative role of hepatic venous flow
56. Studies on the rejection of the transplanted homologous dog liver
57. Liver transplantation with use of cyclosporin A and prednisone
58. Homotransplantation of the liver in humans
59. FK506 for human liver, kidney, and pancreas transplantation
60. Extended preservation of human liver grafts with UW solution
61. Critical ethical issues in clinical trials with xenotransplants
62. Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts
63. Biliary reconstruction without T-tubes or stents in liver transplantation: Report of 502 consecutive cases
64. Adult living donor liver transplantation using a right hepatic lobe
65. Simple hypothermic preservation for transporting human livers long distance for transplantation
66. Use of OKT3 monoclonal antibody as induction therapy for control of rejection in liver transplantation
67. A note on transplantation of the whole liver in dogs
68. A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: A report of the United States FK506 Study Group
69. Recurrent and acquired hepatitis C viral infection in liver transplant recipients